NCT02588937 - Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

June 30, 2017

Conditions

Hepatitis B, Chronic

Interventions

DRUG

EntecaBell ODT. 0.5mg

DRUG

Baraclude Tab. 0.5mg

Trial Locations (9)

Dankook University Hospital, Cheonan

Chungnam National University Hospital, Daejeon

Kyungpook National University Hospital, Daegu

Hanyang University Guri Hospital, Guri-si

Yeungnam University Hospital, Daegu

Jeju National University Hospital, Jeju City

Chonbuk National University Hospital, Jeonju

Chonnam National University Hospital, Gwangju

Konkuk University Chungju Hospital, Chungju